Abdulaziz F. Al Mana

Abdulaziz F. Al Mana

Auto-generated profile, based on publicly available information

Abdulaziz F. Al Mana

Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2020 in American Journal of Clinical Pathology
Verified
Journal Article
Closed access
AEAndrea Espejo-Freire
Andrea Espejo-Freire
YAYamac Akgun
Yamac Akgun
AMAbdulaziz F Al Mana
Abdulaziz F Al Mana
YTYouley Tjendra
Youley Tjendra
NMNicolas C Millan
Nicolas C Millan
Carolyn CrayCarolyn Cray
Carolyn Cray
Objectives: To examine and summarize the current literature on serologic methods for the detection of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Methods: A literature review was performed using searches in databases including PubMed, medRxiv, and bioRxiv. Thirty-two peer-reviewed papers and 23 preprints were examined. Results: The studies included lateral flow immunoassay, enzyme-linked immunosorbent assay, chemiluminescence immunoassay, and neutralizing antibody assays. The use of all major SARS-CoV-2 antigens was demonstrated to have diagnostic value. Assays measuring total antibody reactivity had the highest sensitivity. In addition, all the methods provided opportunities to characterize the humoral immune response by isotype. The combined use of IgM and IgG detection resulted in a higher sensitivity than that observed when detecting either isotype alone. Although IgA was rarely studied, it was also demonstrated to be a sensitive marker of infection, and levels correlated with disease severity and neutralizing activity. Conclusions: The use of serologic testing, in conjunction with reverse transcription polymerase chain reaction testing, was demonstrated to significantly increase the sensitivity of detection of patients infected with SARS-CoV-2. There was conflicting evidence regarding whether antibody titers correlated with clinical severity. However, preliminary investigations indicated some immunoassays may be a surrogate for the prediction of neutralizing antibody titers and the selection of recovered patients for convalescent serum donation.

2 August 2024 in Molecular Diagnosis & Therapy
Verified
Journal Article
Closed access
PDF file
AMAbdulaziz F. Al Mana
Abdulaziz F. Al Mana
KCKristen Culp
Kristen Culp
AKAbby Keeler
Abby Keeler
OPOrlando Perrera
Orlando Perrera
MRMalini Rajagopalan
Malini Rajagopalan
BTBharat Thyagarajan
Bharat Thyagarajan

18 July 2026 in Transfusion Clinique et Biologique
Verified
Journal Article
Closed access
JPJay Patel
Jay Patel
DPDenise L. Pereira
Denise L. Pereira
DGDamian Green
Damian Green
ABAmer Beitinjaneh
Amer Beitinjaneh
NHNoa G. Holtzman
Noa G. Holtzman
AMAbdulaziz F. Al Mana
Abdulaziz F. Al Mana